1. Startpage

Search

Current filters:



Use filters to refine the search results.

Start a new search
Results 11-20 of 38 (Search time: 0.014 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
selective_internal_radiothera-20220914234950293.pdf.jpg20146-Oct-2022Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC) : study protocol for a randomized controlled trialKlöckner, Roman; Ruckes, Christian; Kronfeld, Kai; Wörns, Marcus-Alexander; Weinmann, Arndt; Galle, Peter R.; Lang, Hauke; Otto, Gerd; Eichhorn, Waltraud; Schreckenberger, Mathias; Düber, Christoph; Pitton, Michael B.
efficacy_and_safety_of_a_conv-20220714111608576.pdf.jpg201515-Jul-2022Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantationVollmar, Johanna; Bellmann, Maren Christina; Darstein, Felix; Hoppe-Lotichius, Maria; Mittler, Jens; Heise, Michael; Rüttger, Bernd; Weyer, Veronika; Zimmermann, Anca; Lang, Hauke; Galle, Peter R.; Zimmermann, Tim
diabetic_liver_injury_from_st-20220913193459567.pdf.jpg201314-Sep-2022Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsKohl, Tobias; Gehrke, Nadine; Schad, Arno; Nagel, Michael; Wörns, Marcus-Alexander; Sprinzl, Martin; Zimmermann, Tim; He, You Wen; Galle, Peter R.; Schuchmann, Marcus; Schattenberg, Jörn
sonographic_assessment_of_low-20221206094630446.pdf.jpg20226-Dec-2022Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19 : a prospective single-centre studyKremer, Wolfgang M.; Labenz, Christian; Kuchen, Robert; Sagoschen, Ingo; Bodenstein, Marc; Schreiner, Oliver; Wörns, Marcus-Alexander; Sivanathan, Visvakanth; Weinmann, Arndt; Galle, Peter R.; Sprinzi, Martin F.
impact_of_thyroid_disorders_o-20221206100750093.pdf.jpg20216-Dec-2022Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Armandi, Angelo; Galle, Peter R.; Schattenberg, Jörn M.
58506.pdf.jpg201817-Oct-2018Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaMähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
deletion_of_cd44_inhibits_met-20230802114757395.pdf.jpg20238-Aug-2023Deletion of Cd44 inhibits metastasis formation of liver cancer in Nf2-mutant miceGerardo-Ramírez, Monserrat; Giam, Vanessa; Becker, Diana; Groth, Marco; Hartmann, Nils; Morrison, Helen; May-Simera, Helen L.; Radsak, Markus P.; Marquardt, Jens U.; Galle, Peter R.; Herrlich, Peter; Straub, Beate K.; Hartmann, Monika
hepatocyte_bcl3_protects_from-20230210100315764.pdf.jpg202210-Feb-2023Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failureGehrke, Nadine; Wörns, Marcus A.; Mann, Amrit; Hövelmeyer, Nadine; Waisman, Ari; Straub, Beate K.; Galle, Peter R.; Schattenberg, Jörn M.
significant_liver_fibrosis_is-20221121132447370.pdf.jpg202230-Jan-2023Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIVMichel, Maurice; Wahl, Alisha; Anders, Malena; Alqahtani, Saleh A.; Kremer, Wolfgang M.; Galle, Peter R.; Labenz, Christian; Grimm, Daniel; Sprinzl, Martin; Schattenberg, Jörn M.

Refine search results